Neurofibromin is a novel regulator of adipocyte maturation and function

The Department of the Army Medical Command awarded Augusta University Research Institute, Inc. a $154,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2024.

The grant funds research investigating neurofibromin as a novel regulator of adipocyte maturation and function. Neurofibromin plays an important role in cell growth and differentiation, and this project will advance understanding of its influence on fat cell development and metabolic activity. Insights gained from the research could help transform military and public health by improving treatment and prevention of obesity, diabetes, and other conditions impacted by adipose tissue dysfunction. As the sub-awardee, Augusta University Research Institute will deliver the proposed research services and products to the Department of the Army Medical Command over the two year grant period.